True Private Wealth Advisors Takeda Pharmaceutical CO LTD Transaction History

True Private Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 11, 2021	SELL	$15.39 - $18.97 $692 - $853	-45 Closed	0 $0
Q3 2020 Oct 09, 2020	SELL	$17.1 - $19.19 $3,693 - $4,145	-216 Reduced 82.76%	45 $0
Q2 2020 Jul 07, 2020	SELL	$14.59 - $19.5 $1,298 - $1,735	-89 Reduced 25.43%	261 $4,000
Q1 2020 Apr 20, 2020	SELL	$13.02 - $20.31 $43,994 - $68,627	-3,379 Reduced 90.61%	350 $5,000
Q4 2019 Jan 27, 2020	BUY	$16.88 - $20.83 $62,945 - $77,675	3,729 New	3,729 $73,000
Q3 2019 Oct 09, 2019	SELL	$16.15 - $17.99 $57,703 - $64,278	-3,573 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$16.58 - $20.49 $59,240 - $73,210	3,573 New	3,573 $63,000

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $46.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.